Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma

Clinical trial NCT07148245 · RECRUITING

Trial details

NCT number: NCT07148245
Sponsor: University of California, San Francisco
Status: RECRUITING
Study type: OBSERVATIONAL

Cutaneous Melanoma Cutaneous Melanoma, Stage III Cutaneous Melanoma by AJCC V7 Stage Cutaneous Melanoma, Stage IV

Start date: 2025-10-13
Primary completion: 2027-06-30
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.